Bretisilocin
A chemical compound related to the class of tryptamines
Bretisilocin is a synthetic compound that belongs to the class of tryptamines, which are a group of monoamine alkaloids found in various plants, fungi, and animals. Tryptamines are structurally similar to the neurotransmitter serotonin and are known for their psychoactive properties.
Chemical Structure[edit]

Bretisilocin is characterized by its indole ring structure, which is a common feature of tryptamines. The compound is a derivative of the naturally occurring tryptamine, modified by the addition of various functional groups that alter its pharmacological properties.
Pharmacology[edit]
Bretisilocin acts primarily on the serotonin receptors in the brain. It is known to have a high affinity for the 5-HT2A receptor, which is believed to be responsible for its psychoactive effects. The interaction with these receptors can lead to altered perception, mood, and cognition.
Synthesis[edit]
The synthesis of Bretisilocin involves several steps, starting from the basic indole structure. The process typically includes the introduction of specific substituents at designated positions on the indole ring to achieve the desired pharmacological profile. The synthesis requires careful control of reaction conditions to ensure the correct stereochemistry and purity of the final product.
Potential Uses[edit]
While Bretisilocin is primarily studied for its psychoactive properties, there is ongoing research into its potential therapeutic applications. These include the treatment of certain psychiatric disorders such as depression, anxiety, and post-traumatic stress disorder (PTSD). However, more research is needed to fully understand its efficacy and safety profile.
Legal Status[edit]
The legal status of Bretisilocin varies by country. In many jurisdictions, it is classified as a controlled substance due to its psychoactive effects and potential for abuse. Researchers must obtain special licenses to study the compound in a laboratory setting.
Related Compounds[edit]
Bretisilocin is related to other tryptamines such as psilocybin, DMT, and 5-MeO-DMT. These compounds share similar structural features and pharmacological effects, although each has unique properties that influence their use and regulation.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian